Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Highlights IDWeek 2023
nov 2023 | Bacteriële infecties, HIV, Parasitaire infecties, SOA, Vaccinatie, Virale infecties